A first-in-class tri-complex KRAS(G13C)(ON) inhibitor validates therapeutic targeting of KRAS(G13C)and drives tumor regressions in preclinical models

CANCER RESEARCH(2022)

引用 0|浏览7
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要